StonvexLoading…
StonvexStonvexStonvexCore line items from HAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-20 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $5.54B | $5.40B | $22.18B | $16.53B | $10.93B |
Operating Income | Not available | $679.00M | $2.26B | $1.51B | $1.16B |
Net Income | Not available | $461.00M | $1.28B | $694.00M | $676.00M |
EPS (Diluted) | $0.54 | $0.55 | $1.50 | $0.81 | $0.78 |
Total Assets | Not available | $25.14B | $25.01B | $25.16B | $25.38B |
Total Liabilities | Not available | $14.32B | $14.51B | $14.92B | $14.83B |
Cash & Equivalents | Not available | $2.00B | $2.21B | $2.03B | $2.04B |
Free Cash Flow OCF − CapEx | Not available | $81.00M | $1.67B | $844.00M | $617.00M |
Shares Outstanding | Not available | 839.00M | 835.00M | 858.00M | 862.00M |